MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 482 Shares of Chemed Co. (NYSE:CHE)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 16.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,358 shares of the company's stock after purchasing an additional 482 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Chemed were worth $1,779,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Chemed in the fourth quarter valued at approximately $95,872,000. Freestone Grove Partners LP acquired a new position in shares of Chemed in the fourth quarter valued at approximately $61,664,000. Raymond James Financial Inc. acquired a new position in shares of Chemed in the fourth quarter valued at approximately $42,023,000. Citadel Advisors LLC increased its stake in shares of Chemed by 197.4% in the fourth quarter. Citadel Advisors LLC now owns 77,143 shares of the company's stock valued at $40,870,000 after buying an additional 51,206 shares during the period. Finally, FMR LLC increased its stake in shares of Chemed by 18.9% in the fourth quarter. FMR LLC now owns 283,790 shares of the company's stock valued at $150,352,000 after buying an additional 45,174 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Royal Bank of Canada upped their price objective on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Spencer S. Lee sold 1,500 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president now owns 14,627 shares in the company, valued at $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 7,500 shares of company stock worth $4,401,120. 3.29% of the stock is owned by corporate insiders.

Chemed Price Performance

Shares of Chemed stock traded down $4.22 during midday trading on Wednesday, reaching $576.97. The company had a trading volume of 4,569 shares, compared to its average volume of 102,972. The stock has a fifty day moving average price of $582.46 and a 200 day moving average price of $565.69. The firm has a market cap of $8.44 billion, a PE ratio of 29.15, a P/E/G ratio of 2.15 and a beta of 0.59. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The company had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm's quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.20 earnings per share. As a group, sell-side analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.